Early study data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such results are just the start.
Carlisle Companies Incorporated (NYSE:CSL) today announced that it has entered into a definitive agreement to acquire the expanded polystyrene "EPS" insulation segment of PFB Holdco, Inc., a portfolio ...